Literature DB >> 32119116

Feasibility of a trial to evaluate nicotinamide for chemoprevention of skin cancers in organ transplant recipients in the UK.

C E Gollins1, A Shah2, K Sinha2, S Khan3, N Paul4, B Meeajun5, R A Abbott6, C Blasdale7, H Cooper8, C A Harwood9, F Ismail10, J T Lear11, L Mackintosh12, S McCormack13, C M Perrett14, C M Proby15, A Durack16, R Patalay17, R N Matin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32119116     DOI： 10.1111/bjd.18982

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

Review 1.  Oral nicotinamide for non-melanoma skin cancers: A review.

Authors:  Samantha Vicki Hunt; Aaron Jamison; Raman Malhotra
Journal:  Eye (Lond)       Date:  2022-03-28       Impact factor: 4.456

Review 2.  Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 2: education, training and capacity building.

Authors:  Carron P Layfield; Hywel C Williams
Journal:  Clin Exp Dermatol       Date:  2022-04-13       Impact factor: 4.481
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.